Skip to main content
PhRMA.org Logo
  • About
  • Policy Issues
  • Scientific Innovation
  • Patient Support
  • News
  • Resources
  • Blog
Sites
  • MAT.org
  • PhRMA.org
  • VotersforCures.org
Exit Search
PhRMA.org Logo
Exit Search
  • About
  • Policy Issues
  • Scientific Innovation
  • Patient Support
  • News
  • Resources
  • Blog
  • Sites
  • MAT.org
  • PhRMA.org
  • VotersforCures.org

Search in PhRMA

  • All
  • News
  • Resources
  • Blogs
Search
Explore Policy Issues
  • Patient Centered Agenda
  • Ecosystem Readiness
    • Beating COVID-19
    • Pandemic Preparedness
  • 340B
  • Access to Medicines
    • Cost and Value of Medicine
    • Insurance Coverage and PBMs
    • Price Setting
    • Value Assessment
    • Insulin
  • Drug Importation
  • Drug Shortages
  • Intellectual Property
  • International
  • Medicaid
  • Medicare
    • Part B
    • Part D
    • CMMI
  • Prescription Drug Abuse
  • Research & Development
    • R&D Policy Framework
    • Cell & Gene Therapy
    • FDA
    • PDUFA
    • Venture Capital
    • Manufacturing & Supply Chain
  • STEM
  • Trade

Research & Development

Biopharmaceutical Manufacturing

While the research and development of a medicine is under way, a parallel process is undertaken to develop the manufacturing process and build manufacturing capacity – an often-overlooked part of a medicine’s lifecycle. As the research and development process progresses and researchers get closer to a potential successful treatment, companies must make the transition from manufacturing small exploratory batches of experimental medicines used in clinical trials to safely and efficiently manufacturing a medicine in mass quantities for the public, and they must develop the distribution system to get the medicine to patients. This includes:

  • Establishing a robust manufacturing supply chain;
  • Building the capacity to manufacture sufficient quantities of a medicine for the patients that need it;
  • Developing and implementing supply chain management plans focused on quality controls related to every aspect of manufacturing and efforts to ensure continuity in manufacturing; and
  • Obtaining the appropriate regulatory approvals for any new facilities needed to manufacture the medicine. 

Setting up the manufacturing capacity and all the pieces that go with it is a complex and lengthy process. Building a new manufacturing facility, for example, can cost up to $2 billion and take 5 to 10 years before it is operational, including the time and costs related to comply with various regulatory requirements. Expanding existing facilities and transferring a single product to a new manufacturing site isn’t any simpler. It requires process transfer and scale-up, validation, stability protocols and regulatory filings, which can take several years.

Over decades, biopharmaceutical manufacturers have carefully built these robust global supply chains to ensure patients in the United States and around the world have ongoing access to medicines. The industry is committed to ensuring a safe, stable and secure supply chain, which requires a significant investment in time and resources and ongoing coordination with the U.S. Food and Drug Administration and other regulatory bodies to help prevent and mitigate potential shortages or other disruptions.

 

-

Medicine Safety: Drug Shortages

STEM Education

-

Codes & Guidelines

STEM: Growing Our Next Generation of Innovators

-

State Map: Economic Impact

Related Resources

A graphic showing the first page of PhRMA's fact sheet entitled "How Industry Collaboration and Partnerships are Supporting COVID-19 Vaccine Manufacturing"

How Industry Collaboration and Partnerships are Supporting COVID-19 Vaccine Manufacturing

Fact Sheet

fact sheet

Catalyst: How industry collaboration and partnerships are supporting COVID-19 vaccine manufacturing

Blog

Blog Post
A teaser image featuring PhRMA's recent report titled "Setting up a Pharmaceutical Manufacturing Process and Supply Chain: A Complex and Lengthy Undertaking"

Setting Up A Pharmaceutical Manufacturing Process and Supply Chain: A Complex & Lengthy Undertaking

Fact Sheet

fact sheet
The logo of the blog of the Pharmaceutical Research and Manufacturers of America, or PhRMA, covering America's biopharmaceutical industry

Manufacturing Day 2020: A closer look at the biopharmaceutical industry’s contributions

Blog

Blog Post
The logo of the blog of the Pharmaceutical Research and Manufacturers of America, or PhRMA, covering America's biopharmaceutical industry

By the numbers: A look at the sourcing of API used in medicines consumed in the United States

Blog

Blog Post

Biopharmaceutical Manufacturing in the US

Report

Read More
Graphic of a pie chart

Setting the Record Straight on Pharmaceutical Manufacturing Supply Chains

Fact Sheet

read more
The logo of the blog of the Pharmaceutical Research and Manufacturers of America, or PhRMA, covering America's biopharmaceutical industry

Stakeholders raise concerns with proposed drastic changes to the pharmaceutical supply chain

Blog

Blog Post
The logo of the blog of the Pharmaceutical Research and Manufacturers of America, or PhRMA, covering America's biopharmaceutical industry

Setting up a pharmaceutical manufacturing supply chain is a complex and lengthy process

Blog

Blog Post
The logo of the blog of the Pharmaceutical Research and Manufacturers of America, or PhRMA, covering America's biopharmaceutical industry

It’s a good thing pharmaceutical manufacturing supply chains are spread out around the world

Blog

Blog Post
The logo of the blog of the Pharmaceutical Research and Manufacturers of America, or PhRMA, covering America's biopharmaceutical industry

America’s global leadership in biopharmaceutical manufacturing

Blog

Blog Post
The logo of the blog of the Pharmaceutical Research and Manufacturers of America, or PhRMA, covering America's biopharmaceutical industry

On Manufacturing Day, a closer look at the biopharmaceutical sector’s contributions

Blog

Blog Post
The logo of the blog of the Pharmaceutical Research and Manufacturers of America, or PhRMA, covering America's biopharmaceutical industry

New Report: Advanced manufacturing powering innovative biopharmaceuticals

Blog

Blog Post
A teaser image of PhRMA's COVID-19 Vaccine Manufacturing Collaborations fact sheet

Working Together To Fight COVID-19: Vaccine Manufacturing Collaborations

Fact Sheet

fact sheet
PhRMA.org Logo

PhRMA.Org is now loading ...

Stay Connected

Share

PhRMA Foundation logo
The Voters for Cures logo - Voters for Cures - an initiative from PhRMA
Medicine Assistance Tool logo

  • Members Site
  • Contact Us
  • Privacy Policy
  • Terms of Service
  • Site Map

Pharmaceutical Research and Manufacturers of America®
950 F Street, NW Suite 300, Washington, DC 20004

Please be advised that this page contains pixel tags. To learn more about what pixel tags are, why and how
we and third parties use pixel tags, and how that use affects you, visit our privacy policy and review
"1. Information Collection."